The Lithuanian competition authority Konkurencijos taryba has found that the Lithuanian Pharmacy Association (LPA) and 8 pharmaceutical companies agreed on the margins of reimbursable medicines. The infringement of the Law on Competition and the Treaty on the Functioning of the European Union resulted in more than EUR 72 million in fines.

Konkurencijos taryba cleared the acquisition of joint control of UAB Taikos centras by the Latvian company  New Bumani Invest and Raimundas Petrikas.

On February 24, 2017 the Competition Council terminated the investigation into the requirements for pharmacy premises and equipment approved by the  Ministry of Health in  2003 (hereinafter – Requirements). The investigation was terminated after the Ministry of Health amended the Requirements to ensure equal competitive opportunities...

The Competition Council (hereinafter – Council) found that UAB Nemuno vaistinė (hereinafter – Company) made false claims about 30 per cent cheaper products sold in the pharmacies of Camelia (hereinafter – Camelia ), and thus breached Article 5 of the Law on Advertising.